07.01.2018 15:50:22

New Drugs Approved In December

(RTTNews) - The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval.

Last month, 6 novel drugs were approved, making the total number of novel drug approvals for 2017 to 46. This number compares favorably with 2016, which saw just 22 novel drugs getting the regulatory nod. Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

Here's the list of new drugs, including novel drugs and biosimilars, which were approved in December 2017.

Analysen zu Sanofi S.A. (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Aclaris Therapeutics Inc 2,58 -6,75% Aclaris Therapeutics Inc
Johnson & Johnson 139,14 0,12% Johnson & Johnson
Merck Co. 95,70 -0,10% Merck Co.
Novo Nordisk (spons. ADRs) 83,60 -1,65% Novo Nordisk (spons. ADRs)
Pfizer Inc. 25,43 0,24% Pfizer Inc.
Sanofi S.A. (spons. ADRs) 46,80 1,30% Sanofi S.A. (spons. ADRs)
Sanofi S.A. 93,62 0,32% Sanofi S.A.